| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193198 | Annals of Allergy, Asthma & Immunology | 2008 | 4 Pages |
Abstract
Our report demonstrates that parecoxib does not induce cross-reactivity in patients with a history of urticaria or angioedema. Hence, this finding suggests that this drug could be safely proposed as an alternative (but only after a prior challenge) in patients with previous hypersensitive reactions to NSAIDs, even if there are added risk factors such as atopy and antimicrobial allergy, who require an analgesic drug perioperatively.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Maria Cristina MD, Eustachio MD, Pierluigi MD, Carmela MD, Carmela MD, Anna Maria MD, Elisabetta MD, Antonio MD, Angelo MD,